Rehabilitation Department, Fourth Hospital of Changsha, Changsha 410005, China.
Dis Markers. 2022 Jul 22;2022:3380048. doi: 10.1155/2022/3380048. eCollection 2022.
To investigate the effect of high-frequency chest wall oscillatory expectoration system (HFCWO) on pulmonary rehabilitation and cortisol function in patients with severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
The 65 severe AECOPD patients admitted to our hospital from January 2019 to May 2020 were divided into group A with 33 cases and group B with 32 cases by random number table method. After 14 days of intervention, the improvement time of clinical symptoms in the two groups was recorded, and blood gas, lung function, inflammatory, and cortisol function-related indicators were evaluated before and after treatment.
The remission time of expectoration, pulmonary signs, and hospital stay in group A were significantly shorter than those in group B ( < 0.05). Compared with before treatment, blood oxygen partial pressure (PaO), forced vital capacity (FVC), forced expiratory volume at 1 s (EFV1), and EFV1/FVC increased significantly; blood carbon dioxide partial pressure (PaCO), C-reactive protein (CRP), interleukin-6 (IL-6), white blood cell count (WBC), plasma cortisol (COR), and adrenocorticotropic hormone (ACTH) levels were significantly decreased, and the above indicators in group A increased or decreased more significantly than those in group B ( < 0.05); there was no significant difference in tolerance and adverse reactions between the two groups ( > 0.05).
HFCWO has good pulmonary rehabilitation effect in the treatment of severe AECOPD and can significantly improve the blood gas indexes, inflammation, and cortisol function of patients, which is safe and feasible.
探讨高频胸壁振荡排痰系统(HFCWO)对慢性阻塞性肺疾病急性加重期(AECOPD)患者肺康复及皮质醇功能的影响。
选取我院 2019 年 1 月至 2020 年 5 月收治的 65 例重度 AECOPD 患者,采用随机数字表法分为 A 组(n=33)和 B 组(n=32)。两组均接受常规治疗,A 组在此基础上联合 HFCWO 治疗,比较两组患者的临床症状改善时间,并评价治疗前后血气、肺功能、炎症指标及皮质醇功能相关指标。
A 组患者的排痰、肺部啰音及住院时间均明显短于 B 组( < 0.05)。与治疗前比较,两组患者的血氧分压(PaO)、用力肺活量(FVC)、第 1 秒用力呼气容积(EFV1)、EFV1/FVC 均明显升高,血二氧化碳分压(PaCO)、C 反应蛋白(CRP)、白细胞介素-6(IL-6)、白细胞计数(WBC)、血浆皮质醇(COR)、促肾上腺皮质激素(ACTH)水平均明显降低,且 A 组上述指标的改善程度更为显著( < 0.05);两组患者的耐受度和不良反应发生率比较差异均无统计学意义( > 0.05)。
HFCWO 治疗重度 AECOPD 患者具有良好的肺康复效果,可显著改善患者的血气指标、炎症反应及皮质醇功能,且安全性较高。